Innoviva (INVA) Shareholder's Equity Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.69% |
| Dec 31, 2025 | 27.51% |
| Sep 30, 2025 | 16.34% |
| Jun 30, 2025 | 8.13% |
| Mar 31, 2025 | 5.42% |
| Dec 31, 2024 | 9.53% |
| Sep 30, 2024 | 10.78% |
| Jun 30, 2024 | 19.12% |
| Mar 31, 2024 | 0.33% |
| Dec 31, 2023 | 3.55% |
| Sep 30, 2023 | 5.47% |
| Jun 30, 2023 | 4.05% |
| Mar 31, 2023 | 11.43% |
| Dec 31, 2022 | 18.26% |
| Sep 30, 2022 | 31.24% |
| Jun 30, 2022 | 31.85% |
| Mar 31, 2022 | 40.30% |
| Dec 31, 2021 | 48.98% |
| Sep 30, 2021 | 87.03% |
| Jun 30, 2021 | 65.52% |
| Mar 31, 2021 | 74.07% |
| Dec 31, 2020 | 65.15% |
| Sep 30, 2020 | 63.85% |
| Jun 30, 2020 | 54.12% |
| Mar 31, 2020 | 47.58% |
| Dec 31, 2019 | 43.73% |
| Sep 30, 2019 | 40.46% |
| Jun 30, 2019 | 38.89% |
| Mar 31, 2019 | 36.66% |
| Dec 31, 2018 | 35.07% |
| Sep 30, 2018 | 30.53% |
| Jun 30, 2018 | 19.15% |
| Mar 31, 2018 | 6.48% |
| Dec 31, 2017 | -2.81% |
| Sep 30, 2017 | -4.90% |
| Jun 30, 2017 | -16.53% |
| Mar 31, 2017 | -48.42% |
| Dec 31, 2016 | -47.06% |
| Sep 30, 2016 | -46.04% |
| Jun 30, 2016 | -84.10% |
| Mar 31, 2016 | -81.26% |
| Dec 31, 2015 | -61.47% |
| Sep 30, 2015 | -56.92% |
| Jun 30, 2015 | -52.60% |
| Mar 31, 2015 | -254.18% |
| Dec 31, 2014 | -36.90% |
| Sep 30, 2014 | -48.35% |
| Jun 30, 2014 | -71.03% |
| Dec 31, 2013 | 148.48% |
| Dec 31, 2012 | 41.29% |